Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression
about
Access denied? The status of co-receptor inhibition to counter HIV entryA multi-targeted drug candidate with dual anti-HIV and anti-HSV activityThe development of an AIDS mucosal vaccine.CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation.The Membrane-Proximal Region of C-C Chemokine Receptor Type 5 Participates in the Infection of HIV-1.CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis.MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitroGenomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressorsA nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patientsNatural anti-CCR5 antibodies in HIV-infection and -exposureScarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infectionCCR5: From Natural Resistance to a New Anti-HIV Strategy.Host factors influencing susceptibility to HIV infection and AIDS progression.Inhibition of HIV-1 entry by antibodies: potential viral and cellular targetsIntroduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines.Factors associated with HIV viral load in a respondent driven sample in Los AngelesImproved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134.Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5.Induction of HIV-blocking anti-CCR5 IgA in Peyers's patches without histopathological alterations.Closing two doors of viral entry: intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1.The potent anti-HIV activity of CXCL12gamma correlates with efficient CXCR4 binding and internalizationInduction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based Vector.Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens.The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection.The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5.Collateral efficacy as a pharmacological problem applied to new drug discovery.Strenuous resistance to natural HIV-1 disease progression: viral controllers and long-term nonprogressors
P2860
Q28300187-F6CF9940-7B72-4280-8FCC-91BAF2EB5338Q28534866-61BBF4C0-CCC4-4BA9-9F9C-FB51D4057FABQ30408103-150D61B3-CEED-4ADB-A766-A1077C29B87AQ33305428-A4EE3E49-33EE-4AC3-8F4F-8FD42A4D8A82Q33595068-8FE5E4FB-96A6-408D-96FA-318797E8849AQ33669282-AD5115EB-DDD6-438B-9AE3-AEE0CA571702Q33985740-3974C51B-E2F1-4CFE-88C1-02148495347AQ34079006-66AB9B2D-6ADE-4E66-A7E9-D9B19630B1B0Q34637668-9F8AE2BA-A424-4059-85AA-C3A86CE44871Q35018133-FFCD0D3B-1886-43B8-9AF6-EF5784F6CC0FQ35093052-9F125B25-2331-4839-BE45-91B644D41570Q35185919-0EF0E6E4-0EAA-4F85-A250-8E5623132ABFQ35260605-CDFCD989-BBF1-4521-A3F5-E7304183A5FEQ35995936-354B6E9B-43FD-43EA-85FD-0281E301758DQ36631937-DD5111DD-281B-4D10-9C74-AD961E049519Q36863841-ACB7552A-7068-4773-BA77-C1B76DE50E9CQ37113436-77BB77E9-3CE3-4B91-A8EB-A02BA1B5A868Q37415950-B0A7F09F-CF81-4474-964F-299E344E422BQ37529047-AC2701CE-77F7-49D9-AC5A-C5AFB5353F70Q37713548-F7D6C3F6-1339-4E85-B187-1F4965DC3B0FQ38630677-F6C86C04-1EDB-4F8A-A514-A280676B4371Q39762386-A31AB684-0D13-4DC8-A28D-2DA318F35938Q43094365-99FCA2AC-913C-4EC1-A7E9-1C29969DD1F9Q43112410-A0C1CC7C-75D0-4165-BBF3-740AE47CA197Q47107303-F08C889E-74B8-4BC6-BB7F-51B24E2E6D37Q47240000-2E51E3CF-ED8F-4BA8-A24B-7117B015E967Q53583903-F5065FF2-8E0D-4963-A644-BC9B2C2B5E8AQ58377836-82CEF36B-7D14-4A57-BC11-FC3BA20E6E1F
P2860
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Long-lasting CCR5 internalizat ...... ct against disease progression
@ast
Long-lasting CCR5 internalizat ...... ct against disease progression
@en
type
label
Long-lasting CCR5 internalizat ...... ct against disease progression
@ast
Long-lasting CCR5 internalizat ...... ct against disease progression
@en
prefLabel
Long-lasting CCR5 internalizat ...... ct against disease progression
@ast
Long-lasting CCR5 internalizat ...... ct against disease progression
@en
P2093
P2860
P50
P1433
P1476
Long-lasting CCR5 internalizat ...... ct against disease progression
@en
P2093
Barbara Weiser
Claudia Barassi
Claudia Pastori
Giliola Calori
Guido Poli
Harold Burger
Kimdar Kemal
Renato Longhi
Silvia Ghezzi
P2860
P304
P356
10.1182/BLOOD-2005-06-2463
P407
P577
2006-03-07T00:00:00Z